F810-0413 Screening compound: N-(4-fluorobenzyl)-2-[9-fluoro-3-oxo[1,2,4]triazolo[4,3-c]quinazolin-2(3H)-yl]acetamide

F810-0413 Screening compound: N-(4-fluorobenzyl)-2-[9-fluoro-3-oxo[1,2,4]triazolo[4,3-c]quinazolin-2(3H)-yl]acetamide
F810-0413 Screening compound: N-(4-fluorobenzyl)-2-[9-fluoro-3-oxo[1,2,4]triazolo[4,3-c]quinazolin-2(3H)-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F810-0413
N-(4-fluorobenzyl)-2-[9-fluoro-3-oxo[1,2,4]triazolo[4,3-c]quinazolin-2(3H)-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F810-0413

Molecular Formula

C18H13F2N5O2 (C18 H13 F2 N5 O2)

Compound Name

N-(4-fluorobenzyl)-2-[9-fluoro-3-oxo[1,2,4]triazolo[4,3-c]quinazolin-2(3H)-yl]acetamide

IUPAC name

2-{9-fluoro-3-oxo-2H3H-[124]triazolo[43-c]quinazolin-2-yl}-N-[(4-fluorophenyl)methyl]acetamide

SMILES

O=C(CN1N=C(c(cc(cc2)F)c2N=C2)N2C1=O)NCc(cc1)ccc1F

InChI

InChI=1S/C18H13F2N5O2/c19-12-3-1-11(2-4-12)8-21-16(26)9-25-18(27)24-10-22-15-6-5-13(20)7-14(15)17(24)23-25/h1-7,10H,8-9H2,(H,21,26)

InChI Key

OHWAKUUYLDDDBJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27193047

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

369.33

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.916

Distribution Coefficient, logD

1.916

Water Solubility, LogSw

-2.92

Polar Surface Area

66.159

Acid Dissociation Constant (pKa)

13.40

Base Dissociation Constant (pKb)

3.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

11.11

F810-0413 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F810-0413 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F810-0413?
Check Price and Availability of F810-0413, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F810-0413 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F810-0413
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F810-0413
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F810-0413 available by request